10 reports

Unmet Needs of the Asthma ##.

  • Asthma
  • France
  • Germany
  • Italy
  • Spain

Asthma -Epidemiology Forecast to 2027 ##.

  • Asthma
  • France
  • Germany
  • Italy
  • Spain

Asthma : ##MM Market Analysis ##. ##. ##MM Market Size of Asthma ##. ##. ##MM Percentage Share of drugs marketed for Asthma ##. ##. ##MM Market Sales of Asthma by Products ##.

  • Asthma
  • France
  • Germany
  • Italy
  • United Kingdom
  • 11/14/2017: FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA
  • 01/10/2018: ASTRAZENECA RECEIVES EU APPROVAL OF FASENRA FOR SEVERE EOSINOPHILIC ASTHMA
  • Asthma
  • Japan
  • United States
  • Company
  • Kyowa Hakko Kirin Co., Ltd.
  • Jul 21, 2016: Stop the rogue ADAM gene and you stop asthma
  • Mar 10, 2016: New study to assess why 'rogue gene' causes asthma in early life
  • Asthma
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • GlobalData's company
  • CBIO COMPLETES PRIVATE PLACEMENT OF COMMON STOCK FOR US$1.8 MILLION
  • CBIO COMPLETES PRIVATE PLACEMENT OF SHARES FOR US$2.4 MILLION

The partnership enables both companies to provide treatment to people suffering from asthma.

  • Asthma
  • Pharmaceutical
  • Australia
  • M&A
  • Invion Limited
  • Nov 14, 2017: $8.5M Grant Awarded to Improve Asthma Care with the Navajo Nation
  • Nov 14, 2017: $8.5 million grant awarded to improve asthma care with the Navajo nation
  • Asthma
  • Healthcare
  • Pharmaceutical
  • United States
  • GlobalData's company
  • Nov 10, 2017: Short-circuiting dangerous immune cells to treat asthma
  • Asthma
  • Health Care Provider
  • Pharmaceutical
  • Australia
  • GlobalData's company
  • PHARMAXIS ENTERS INTO PARTNERSHIP WITH SYNAIRGEN
  • PARTNERSHIPS

Its BioBank comprises blood, sputum, nasal lavage, biopsies, bronchial epithelial cells and fibroblasts from volunteers with asthma and COPD.

  • Asthma
  • Pharmaceutical
  • Australia
  • United States
  • Pharmaxis Ltd
  • MAY 24, 2017: USCOM SPIROSONIC DEVICES FOR FRENCH LUNG TRANSPLANT STUDY
  • OTHER LOCATIONS & SUBSIDIARIES

These premium digital devices are changing the way we diagnose and treat cardiovascular and pulmonary diseases, including hypertension, heart failure, asthma, COPD and sleep disorders.

  • Asthma
  • Australia
  • Spain
  • M&A
  • Uscom Ltd